Evidence that inhibition of spinal nitric oxide production contributes to the antinociceptive effects of emulsified isoflurane on formalin-induced pain in rats

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 10, 2008, Pages 1245-1251

  Ge, Zhi Jun ^a   Tan, Yong Fei ^a   Zhao, Yan Ping ^a   Cui, Guo Xing ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Analgesia; Emulsified isofluane; N methyl d aspartate receptor; Nitric oxide; Nitric oxide synthase; Pain; Spinal cord

Indexed keywords

ARGININE; FORMALDEHYDE; ISOFLURANE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN FOS; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BIOSYNTHESIS; CELL LABELING; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME REGULATION; FEMALE; HISTOCHEMISTRY; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NOCICEPTION; NONHUMAN; PAIN; RAT; SPINAL CORD; SPINAL CORD DORSAL HORN; SPINAL CORD NERVE CELL;

ANALGESICS; ANIMALS; EMULSIFYING AGENTS; FEMALE; INJECTIONS, SPINAL; ISOFLURANE; MALE; NITRIC OXIDE; PAIN; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 50649106437     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.05001.x     Document Type: Article

References (21)

1. Kingery WS, Agashe GS, Guo TZ et al. Isoflurane and nociception: Spinal alpha2A adrenoceptors mediate antinociception while supraspinal alpha1 adrenoceptors mediate pronociception. Anesthesiology 2002 96 : 367 74.
2. Antognini JF, Schwartz K. Exaggerated anesthetic requirements in the preferentially anesthetized brain. Anesthesiology 1993 79 : 1244 9.
3. Franks NP, Lieb. WR. Molecular and cellular mechanisms of general anaesthesia. Nature 1994 367 : 607 14.
4. Dog rul A, Ossipov MH, Lai J, Malan TP, Porreca F. Peripheral and spinal antihyperalgesic activity of SIB-1757, a metabotropic glutamate receptor (mGLUR(5)) antagonist, in experimental neuropathic pain in rats. Neurosci. Lett. 2000 292 : 115 18.
5. Omote K, Kawamata T, Kawamata M, Nakayama Y, Hazama K, Namiki A. Activation of peripheral NMDA-nitric oxide cascade in formalin test. Anesthesiology 2000 93 : 173 8.
6. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neuosci. 1991 14 : 60 7.
7. Kawamata T, Omote K. Activation of spinal N-methyl-d-aspartate receptors stimulates a nitric oxide/cyclic guanosine 3,5-monophosphate/glutamate release cascade in nociceptive signaling, while a high dose of zymosan appears to disturb it. Anesthesiology 1999 91 : 1415 24.
8. Nazli M, Hismiogullari ES, Thippeswamy T, Morris R. How central is nitric oxide (NO) to the activation of neurones following noxious peripheral stimulation in the rat? Brain Res. 2001 88 : 172 5.
9. Ishizaki K, Sasaki M, Karasawa S, Obata H, Nara T, Goto F. Intrathecal co-administration of NMDA antagonist and NK-1 antagonist reduces MAC of isoflurane in rats. Acta Anaesthesiol. Scand. 1999 43 : 753 9.
10. Hang LH, Shao DH, Yang YH, Dai TJ, Zeng YM. Spinal α-amino-3- hydroxy-5-methyl-4-isoxazolepropionic acid receptors may mediate the analgesic effects of emulsified halogenated anaesthetics. Clin. Exp. Pharmacol. Physiol. 2007 34 : 1121 5.
11. Toda N, Toda H, Hatano Y. Nitric oxide: Involvement in the effects of anesthetic agents. Anesthesiology 2007 107 : 822 42.
12. Sonner JM, Antognini JF, Dutton RC et al. Inhaled anesthetics and immobility: Mechanisms, mysteries, and minimum alveolar anesthetic concentration. Anesth. Analg. 2003 97 : 718 40.
13. Chiari PC, Pagel PS, Tanaka K, Krolikowski JG, Ludwig LM, Trillo Jr RA. Intravenous emulsified halogenated anesthetics produce acute and delayed preconditioning against myocardial infarction in rabbits. Anesthesiology 2004 101 : 1160 6.
14. Fusun B, Ahmet DM, Oguz G. The involvement of nitric oxide in the analgesic effects of ketamine. Life Sci. 2002 71 : 841 53.
15. Cadena MI, Banuelos PI, Soto VG. Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive effects of nimesulide. J. Pharmacol. Toxicol. Methods 1999 42 : 87 92.
16. Soto VG, Rufino MO, Lopes LD, Ferreira SH. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. Eur. J. Pharmacol. 1997 340 : 177 80.
17. Abacioglu N, Tunctan B, Akbulut E, Cakici I. Participation of the components of l-arginine/nitric oxide/cGMP cascade by chemically-induced abdominal constriction in the mouse. Life Sci. 2000 67 : 1127 37.
18. Malmberg AB, Yaksh TL. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain 1993 54 : 291 300.
19. Pajewski TN, DiFazio CA, Moscicki JC, Johns RA. Nitric oxide synthase inhibitors, 7-nitroindazole and nitroG-L-arginine methyl ester, dose dependently reduce the threshold for isoflurane anesthesia. Anesthesiology 1996 85 : 1111 19.
20. Harris JA. Using c-fos as a neural marker of pain. Brain Res. Bull. 1998 45 : 1 8.
21. Cao JL, Ding HL, He JH, Zhang LC, Duan SHM, Zeng YM. The spinal nitric oxide involved in the inhibitory effect of midazolam on morphine-induced analgesia tolerance. Pharmacol. Biochem. Behav. 2005 80 : 493 503.